QGAI.US Quantum Genesis AI Corp.
- Market cap
- USD 2.46M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Apr 2026.
Is QGAI.US undervalued?
Graham numberThe Graham number of Quantum Genesis AI Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Quantum Genesis AI Corp. fundamental analysis
No fundamental analysis for Quantum Genesis AI Corp. yet.
Quantum Genesis AI Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Quantum Genesis AI Corp.
Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name t…
Full company profileQuantum Genesis AI Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Apr 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Quantum Genesis AI Corp. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|
| Income Statement | |||
| Revenue | 0.00 | 0.00 | 0.00 |
| Operating Income | -164K | -181K | -79.5K |
| EBITDA | -164K | -178K | -5.85M |
| Net Income | -179K | -199K | -5.87M |
| EPS | -0.01 | -0.01 | -0.14 |
| Balance Sheet | |||
| Total Assets | 10.0K | 584.00 | 59.00 |
| Total Liabilities | 293K | 441K | 443K |
| Shareholders' Equity | -283K | -441K | -443K |
| Cash & Short-term Investments | 0.00 | 584.00 | 59.00 |
| Cash Flow | |||
| Operating Cash Flow | -102K | -125K | -83.9K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -102K | -125K | -83.9K |
| Ratios | |||
| ROA | -1,785.7% | -34,121.4% | -9,953,529.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
Quantum Genesis AI Corp. dividends
Quantum Genesis AI Corp. has not paid dividends in the last 2 fiscal years.
Last stock split: 1:100 on May 23, 2023.
Who owns Quantum Genesis AI Corp.
- Insiders 75.66%
- Institutions 0.00%
- Public & others 24.34%
- Shares outstanding 41.0M
- Free float 9.97M
Quantum Genesis AI Corp. company profile
- Company name
- Quantum Genesis AI Corp.
- Ticker
- QGAI.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Employees
- 1
- Fiscal year end
- July
- Address
- 15656 Bernardo Center Drive, San Diego, CA, United States, 92127
- Phone
- 858 203 0312
- Website
- qgaicorp.com
About Quantum Genesis AI Corp.
Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. was incorporated in 2015 and is based in San Diego, California.
Quantum Genesis AI Corp. management
1- Mr. Naveen Krishnarao KulkarniCEO, CFO, President, Secretary, Treasurer & Director · born 1976